Skip to main content

Table 5 Major resistance patterns identified among bacterial isolates; 1st National Prevalence study, Benin, October 2012

From: Prevalence of nosocomial infections and anti-infective therapy in Benin: results of the first nationwide survey in 2012

MRSA (n = 142/271) 52.5%
MRSA vancomycin R (n = 11/142) 7.7%
Enterococcus ampicillin R (n = 64/102) 62.7%
Enterococcus vancomycin R (n = 69/102) 67.6%
E. coli cefotaxime R (n = 89/221) 40.2%
E. coli ESBL + (n = 44/221) 20.0%
Acinetobacter baumanii ceftazidimeR (n = 10/10) 100.0%
Pseudomonas aeruginosa ceftazidime R (n = 75/110) 68.2%
  1. R, resistant; MRSA, methicillin-resistant S. aureus;
  2. ESBL, extended-spectrum beta-lactamase.